ipdi/peg-15 soyamine oxide copolymer은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

ipdi/peg-15 soyamine oxide copolymer은 임신 중 안전한가요?

No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment specific to this named copolymer was identified, and no peer‑reviewed reproductive toxicity data were found indicating developmental/teratogenic effects. As a high‑molecular‑weight polymeric surfactant, systemic absorption from topical use is expected to be negligible, supporting a default low hazard conclusion (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, CosIng, PubChem).

ipdi/peg-15 soyamine oxide copolymer은 모유 수유 중 안전한가요?

No data or regulatory flags indicating reproductive or lactation transfer hazards. Given the polymeric/high‑MW nature and lack of systemic toxicity data, breastmilk transfer is unlikely; no SCCS/CIR contraindication located.

ipdi/peg-15 soyamine oxide copolymer은 아기 피부에 안전한가요?

Hazard and mechanism: no infant‑specific evidence of reproductive or developmental toxicity. Exposure: adult dermal absorption expected negligible (e=0) but per instruction increased by +1 for infants due to immature barrier and higher surface‑area‑to‑weight, yielding e=1. If residual low‑MW impurities (e.g., unreacted IPDI) are present, infant exposure assessment should consider those impurities specifically.

VeriMom은 ipdi/peg-15 soyamine oxide copolymer을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 ipdi/peg-15 soyamine oxide copolymer을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 ipdi/peg-15 soyamine oxide copolymer 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.